Metal-based drugs are privileged motifs that act as primary pharmacophores in bioactive
compounds for various diseases, including tuberculosis (TB). This potentially life-threatening …

In metal-peptide interactions, cations form stable complexes through bonds with
coordinating groups as side chains of amino acids. These compounds, among other things …

Two new salicylaldimine-based N-heterocyclic hydrazone ligands, N'-[(2-hydroxyphenyl)
methylene]-2-(2-phenyl-1H-benzimidazol-1-yl) acetohydrazone (H 2 L 1) and 2-[2-(3 …

Here, we report four new heteroleptic Cu (II) complexes with the formula [Cu
(bipy)(2H4MeBz)] NO 3 (1),[Cu (phen)(2H4MeBz)] NO 3 (2),[Cu (bipy)(2H4OcBz)] NO 3 (3) …

New nanometer Cu (II)-benzohydrazide complexes were synthesized and characterized.
Mono negative tetra-dentate mode is the general feature proposed for all coordinating …

Very few inorganic antineoplastic drugs have entered the clinic in the last decades, mainly
because of toxicity issues. Because copper is an essential trace element of ubiquitous …

A photochemically dissociating ligand in Ru (bpy) 2 (dmphen) Cl2 [bpy= 2, 2′-bipyridine;
dmphen= 2, 9-dimethyl-1, 10-phenanthroline] was found to be more cytotoxic on the ML-2 …

The thin line between efficacy and toxicity has challenged cancer therapy. As copper is an
essential micronutrient and is important to tumor biology, CuII complexes emerged as an …

In this work, three nickel (II) complexes, namely,[Ni (η 2-NO 3)(bta)(phen)](I),[Ni (η 2-NO
3)(btc)(phen)](II), and [Ni (η 2-NO 3)(btf)(phen)](III)(bta= 4, 4, 4-trifluoro-1-phenyl-1, 3 …

Two new bismuth (III) complexes,[BiL 1 Cl 2](1) and [BiL 2 Cl 2](2), in which L 1 is (2-hydroxy-
4-6-di-tert-butylbenzyl-2-pyridylmethyl) amine and L 2 is 2, 4-diiodo-6-((pyridine-2 …